Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-14 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-14 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-13 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-12 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-14 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |